Mark Spiecker

President at STAQ Pharma

Mark Spiecker is the President of STAQ Pharma, a 503B outsourcing facility that provides sterile injectable compounded medications to hospitals across the United States.1 2 He has been in this role since November 2017.3

Professional Background

Mark has extensive experience in the life sciences and biotech industries, spanning over a decade in medical device and pharmaceutical development and manufacturing.5 His career includes several leadership positions:

CEO of Sharklet Technologies (2008-2017), where he led the company's growth and successful sale to a Chinese bioscience group in 20173 5
Director of Restructuring and Investor Relations at Adelphia Communications Corporation (2003-2007)3
Performance Improvement Project Manager at Louisiana-Pacific Corporation (1999-2001)3
Various roles at Tricon Global Restaurants (now YUM Brands) from 1992 to 19993

Education

Mark holds an MBA from Rockhurst University, as well as a B.S.BA. in Marketing from the same institution. He also has an A.A. from the University of Florida.2

Community Involvement

Mark is actively involved in various community and industry organizations:

Board Member and Vice Chair of the Denver Metro Chamber of Commerce2
Trustee at the Denver Museum of Nature and Science2 5
Advisor to the Institute for Science Policy2
Former Chair of the Board of the Colorado Biosciences Association1 5

Expertise

Mark is known for his skills in:

Business development
Process improvement
Innovative operations
Guiding organizations through significant change1 2

At STAQ Pharma, Mark leads the company in providing high-quality compounded medications while adhering to strict cGMP standards, focusing on safety, transparency, availability, and quality in the pharmaceutical industry.3 4